Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | PL4 - Contemporary Clinical Issues Plenary Session

Monday 04/15/24
09:15 AM - 11:00 AM MDT Add To Calendar
Colorado Convention Center | Bellco Theatre
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Plenary Session
Elizabeth Felton
General Neurology
This session highilghts issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments already affecting the practice of neurology.
1.75 CME credits
Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement
Intermediate
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Didactic

Program Materials Program Evaluations

Event Timeline
09:15 AM - 09:25 AM MDT Speaker Presenter: Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment
Christopher Gibbons
09:25 AM - 09:35 AM MDT Speaker Discussant: Cutaneous Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies and Mild Cognitive Impairment
Sonja Scholz
09:35 AM - 09:45 AM MDT Speaker Presenter: The Role of Neurocritical Care Specialists in Brain Death Testing
Neil Dhruva
09:45 AM - 09:55 AM MDT Speaker Discussant: The Role of Neurocritical Care Specialists in Brain Death Testing
Ariane Lewis
09:55 AM - 10:05 AM MDT Speaker Presenter: The Association Between Neighborhood Disadvantage and Subjective Cognitive Functioning Among Black Women
10:05 AM - 10:15 AM MDT Speaker Discussant: The Association Between Neighborhood Disadvantage and Subjective Cognitive Functioning Among Black Women
Raina Croff
10:15 AM - 10:25 AM MDT Speaker Presenter: Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications
Prashanth Rajarajan
10:25 AM - 10:35 AM MDT Speaker Discussant: Multi-institutional Study of Neurologic Outcomes in People with Multiple Sclerosis Who Are Treated with Immune Checkpoint Inhibitors for Oncologic Indications
Kristin Galetta
10:35 AM - 10:45 AM MDT Speaker Presenter: Prevalence and Co-morbidities of GI Disorders in Migraine in Large Tertiary Medical Center
Natalia Murinova
10:45 AM - 10:55 AM MDT Speaker Discussant: Prevalence and Co-morbidities of GI Disorders in Migraine in Large Tertiary Medical Center
Bridget Mueller
Faculty Disclosures
Elizabeth Felton Dr. Felton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Felton has received personal compensation in the range of $500-$4,999 for serving as a Conference Speaker with American Epilepsy Society.
Christopher Gibbons Dr. Gibbons has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience. Dr. Gibbons has stock in CND Life Sciences. Dr. Gibbons has received publishing royalties from a publication relating to health care. Dr. Gibbons has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Advisor with Department of Justice.
Sonja Scholz Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. An immediate family member of Dr. Scholz has received personal compensation for serving as an employee of National Institutes of Health. The institution of Dr. Scholz has received research support from National Institutes of Health. The institution of an immediate family member of Dr. Scholz has received research support from National Institutes of Health. An immediate family member of Dr. Scholz has received intellectual property interests from a discovery or technology relating to health care. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Council Member with Lewy Body Dementia Association that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with JAMA Neurology that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Editorial Board Member with Journal of Parkinson's Disease that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The Multiple System Atrophy Coalition that is relevant to AAN interests or activities. Dr. Scholz has a non-compensated relationship as a Scientific Advisory Board Member with The GBA1 Canada Initiative (G-Can) that is relevant to AAN interests or activities.
Neil Dhruva Mr. Dhruva has nothing to disclose.
Ariane Lewis Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
No disclosure on file
Prashanth Rajarajan Dr. Rajarajan has nothing to disclose.
Kristin Galetta Dr. Galetta has nothing to disclose.
Bridget Mueller Dr. Mueller has nothing to disclose.
Natalia Murinova Dr. Murinova has nothing to disclose.
Raina Croff The institution of Dr. Croff has received research support from Roybal Center for Translational Research. The institution of Dr. Croff has received research support from National Institute on Aging. The institution of Dr. Croff has received research support from National Center for Advancing Translational Science.